Drug Profile
LAS 33774
Latest Information Update: 04 Aug 2005
Price :
$50
*
At a glance
- Originator Almirall-Prodesfarma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 04 Aug 2005 No development reported - Phase-I for Atopic dermatitis in Spain (unspecified route)
- 10 Jul 2003 Phase-I clinical trials in Atopic dermatitis in Spain (unspecified route)
- 07 Jun 2001 This compound is still in active development